Pharma's Future - Strategic discussion comes to London with Pharma Integrates 2012

On the 28th and 29th November 2012 influential leaders in the Pharma world will converge in London for this year's must attend event Pharma Integrates 2012. With speakers of the calibre of Dr Joseph DiMasi, Director Economic Analysis, Tufts Centre for the Study of Drug Development and Tommy Dolan, VP Drug Product Design & Supply, Pfizer, anyone interested in the future of the pharmaceutical industry and how strategic partnerships will create growth, will be attending.

The central questions being considered on the two day retreat all revolve around future productivity, partnership opportunities, barriers to innovation and prospects in the emerging economies through collaboration.

Discussions and Panel sessions will be directed by senior executives from across the pharmaceutical industry such as Wes Wheeler CEO, Marken and Dr Peter Comes Corporate VP End-to-End Supply Network Strategy, Boehringer Ingelheim. Attendees will therefore benefit from a unique opportunity to engage in truly open, interactive and thought provoking discussion about the future of their industry.

Mark Cassidy, Chairperson, Pharma Integrates 2012 and President API Services, Piramal Healthcare commented on why there has been so much interest in producing this event, "The ability to identify and develop strong trusting partnerships will be one of the key competitive differentiators for any stakeholder in this industry."

Pharma Integrates 2012 has been organised by pharmaceutical event specialists Life Sciences Index. There are a limited number of delegate places remaining, so if you are interested in attending visit www.lifesciencesindex.com or contact the organisers Christopher Watt and/or Samuel Thangiah straight away on +44 1883 332 676 for more information.

SCC members receive an exclusive 20% discount off registration.  To receive the discount, use code SCCPI2012 during registration.  Visit http://www.lifesciencesindex.com/pharma-integrates-2012 to register.